•  
  •  
  •  
  •  

2025-11-28 18:06:59

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Marsons Ltd receives LOA worth Rs. 13.46 crores
  • Fabelle Premium Gifting: A New Language of Luxury for Every Celebration
  • Amrutanjan Healthcare Re-launches Its Iconic Yellow Balm
  • Silver is knocking on the breakout door once again
  • Senco Gold & Diamonds unveils breathtaking new Wedding Collection with Kiara Advani

Keywords Selected:  NDA

Research

  • India Inc revenue growth likely moderated to 4-6% in March quarter - CRISIL Market Intelligence and Analytics

Stock Report

  • Biocon Pharma Ltd receives approval from USFDA for its ANDA
  • B and A Ltd consolidated Q2FY26 net profit at Rs. 25.49 crores
  • Caplin Steriles Ltd receives USFDA approval for ANDA Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection
  • BCL Industries Ltd issued 50,077 I-RECs for 60 TPH Biomass Power Plant
  • FDC Ltd receives USFDA approval for ANDA Pilocarpine Hydrochloride Ophthalmic Solutions
  • Hiliks Technologies Ltd receives sub-contract from MSR-MEDIKONDA JV
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Wockhardt Submits New Drug Application to U.S. FDA for Zidebactam-Cefepime for Treatment of Serious GramNegative Infections
  • Electronics Mart India Ltd opens new Bajaj Electronics store at Nalgonda
  • Caplin Steriles Ltd granted final approval for ANDA Milrinone Lactate in 5% Dextrose Injection by USFDA
  • Lupin receives U.S. FDA approval for Risperidone Long-Acting Injectable, with 180-Day CGT Exclusivity
  • Gland Pharma receives approval for Vasopressin in 5% Dextrose RTU Injection
  • Lupin receives approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Gel
  • Alembic Pharmaceuticals Ltd announces USFDA Final Approval for 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials
  • Granules India Ltd receives 1 observation from USFDA for Chantilly facility
  • J.B. Chemicals & Pharmaceuticals Ltd receives USFDA approval for ANDA Amitriptyline Hydrochloride Tablets
  • Lupin launches Prucalopride tablets in the United States
  • Lupin receives approval from U.S. FDA for Prucalopride Tablets
  • J B Chemicals and Pharmaceuticals Ltd receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
  • Uno Minda to Set Up Greenfield Aluminium Die Casting Facility in Maharashtra to Support Growing EV Demand
  • EUROGRIP TYRES partners with HONDA TAIWAN
  • Lupin receives tentative approval from U.S. FDA for Oxcarbazepine ER Tablets
  • Gland Pharma Receives Approval for Angiotensin II Acetate Injection
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Amlodipine and Atorvastatin Tablets USP

Latest Post

  • Marsons Ltd receives LOA worth Rs. 13.46 crores
  • Fabelle Premium Gifting: A New Language of Luxury for Every Celebration
  • Amrutanjan Healthcare Re-launches Its Iconic Yellow Balm
  • Silver is knocking on the breakout door once again
  • Senco Gold & Diamonds unveils breathtaking new Wedding Collection with Kiara Advani


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024